Search

everythinglearnresearchcommunity

for

Search:↓

Patients with hidradenitis suppurativa have higher levels of cell-free DNA in their blood.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

PCOS is linked to chronic low-grade inflammation, but the role of certain infections is unclear.

Stress can trigger and worsen vitiligo.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Men with androgenetic alopecia, or hair loss, often have abnormal blood flow in their small blood vessels, which might be linked to inflammation and stress.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Scleroderma patients have lower hair miR-29a levels.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

The treatment combination is effective and generally safe for lung cancer.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Diffuse hair loss in women is often linked to thyroid problems.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Tph cells are linked to the severity of systemic lupus erythematosus.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Epigenetic changes in blood cells may contribute to alopecia areata.

Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.